Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Non-cell-derived polypeptide-sensitized DC-CIK cells, and construction method and application thereof

A technology of DC-CIK and construction method, which is applied in the direction of animal cells, vertebrate cells, cell culture active agents, etc., and can solve the problems of unclear specific antigen and limited anti-tumor effect

Active Publication Date: 2018-07-06
SHANGHAI UNIV +1
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the lack of specific antigens in many tumors or the lack of specific antigens, the in vivo anti-tumor effect of DC-CIK cells sensitized by tumor antigens is limited.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Non-cell-derived polypeptide-sensitized DC-CIK cells, and construction method and application thereof
  • Non-cell-derived polypeptide-sensitized DC-CIK cells, and construction method and application thereof
  • Non-cell-derived polypeptide-sensitized DC-CIK cells, and construction method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0061]Embodiment 1: the culture of A1-DC-CIK cell (can refer to figure 1 shown)

[0062] 1. Isolation of mononuclear cells

[0063] 1) Take 20ml of peripheral blood from healthy volunteers, anticoagulate with heparin, and centrifuge at 400-600g for 20-40min at room temperature.

[0064] 2) After centrifugation, carefully draw the upper layer liquid with a pipette gun, stop when it is about 0.5 cm away from the buffy coat layer containing mononuclear cells, and discard the upper layer liquid.

[0065] 3) Carefully transfer the buffy coat to a new centrifuge tube with a pipette gun, add an appropriate amount of PBS to the centrifuge tube, and add more liquid than the buffy coat. Centrifuge at 200-300g for 5-10 minutes.

[0066] 4) Discard the supernatant, resuspend the cells with 5-10ml PBS, blow and wash gently with a pipette gun, and centrifuge at 200-300g for 5-10min.

[0067] 5) Repeat 4), discard the supernatant, resuspend the cells with RPMI-1640 complete medium contai...

Embodiment 2

[0092] Embodiment 2: the culture of HCBP1-DC-CIK cell (see figure 1 shown)

[0093] 1. Isolation of mononuclear cells

[0094] 1) Take 20ml of peripheral blood from healthy volunteers, anticoagulate with heparin, and centrifuge at 400-600g for 20-40min at room temperature.

[0095] 2) After centrifugation, carefully draw the upper layer liquid with a pipette gun, stop when it is about 0.5 cm away from the buffy coat layer containing mononuclear cells, and discard the upper layer liquid.

[0096] 3) Carefully transfer the buffy coat to a new centrifuge tube with a pipette gun, add an appropriate amount of PBS to the centrifuge tube, and add more liquid than the buffy coat. Centrifuge at 200-300g for 5-10 minutes.

[0097] 4) Discard the supernatant, resuspend the cells with 5-10ml PBS, blow and wash gently with a pipette gun, and centrifuge at 200-300g for 5-10min.

[0098] 5) Repeat 4), discard the supernatant, resuspend the cells with RPMI-1640 complete medium containing ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses non-cell-derived polypeptide-sensitized DC-CIK cells, and a construction method and application thereof. In a plurality of typical embodiments, the construction method comprises the following steps: acquiring peripheral blood, and carrying out isolating to obtain mononuclear cells; isolating mononuclear cells to obtain monocytes and lymphocytes; inducing the differentiationof the monocytes into mature polypeptide-sensitized DC; inducing the differentiation of the lymphocytes into CIK cells; and subjecting the DC and CIK cells to co-culture so as to obtain the polypeptide-sensitized DC-CIK cells. The DC-CIK cells prepared in the invention have high proliferation activity, can specifically kill tumors and are high in tumoricidal activity; and the construction methodhas low requirements on equipment, and is simple in process, easily controllable in conditions and suitable for large-scale implementation.

Description

technical field [0001] The invention particularly relates to a DC-CIK cell sensitized by a non-cell derived polypeptide, its construction method and application, and belongs to the field of biotechnology. Background technique [0002] Cytokine-induced killer cells (CIK) originally refer to a type of CD3 that exists in the peripheral blood of normal people + CD56 + The normal content of T lymphocytes is about 1%-5%. It is also distributed in the liver, and the distribution is the most, followed by peripheral blood, but the existence of this cell has not been found in human bone marrow cells so far. In 1991, Schmidt-wolf et al reported for the first time that adding a series of cytokines to human peripheral blood lymphocytes in vitro could induce a large number of immune-killing cells, namely CIK cells. CIK cells express both CD3 and CD56 double-positive molecules on the surface, so they have both the strong anti-tumor activity of T lymphocytes and the non-major histocompat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/0784C12N5/0783A61K35/17A61K39/00A61P35/00
CPCA61K39/0011A61K2035/124A61K2039/5154A61K2039/5158C12N5/0639C12N5/0646C12N2501/22C12N2501/2302C12N2501/2304C12N2501/2315C12N2501/24C12N2501/25C12N2501/515
Inventor 朱毅敏崔雪原李春林赵梦雅
Owner SHANGHAI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com